Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine Intravitreal Implant in Glaucomatous Optic Neuropathy
NCT00693485Phase 2Completed
- Sponsor
- Allergan
- Start
- Sep 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of brimonidine in Open-angle glaucoma (OAG), sponsored by Allergan. Started Sep 2008; status: completed.
02
Drugs
brimonidine
03
Conditions
Open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT00693485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693485.